Application 020414

Type
NDA
Sponsor
US ARMY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PYRIDOSTIGMINE BROMIDEPYRIDOSTIGMINE BROMIDETABLET;ORAL30MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020414-001PYRIDOSTIGMINE BROMIDEPYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-0531067a03dcf5…
2025-08-23 18:47 UTC2025-08N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-056a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-0503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-052680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-055bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-0579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-051e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-058072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-055c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-055d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-054b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-0574a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-0587673890dc5c…
2021-03-12 10:30 UTC2021-03N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-055aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-058869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-053f01610625f2…
2019-09-15 20:21 UTC2019-09N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05b00525d2431f…
2019-07-19 19:46 UTC2019-07N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-056a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-051c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-059b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-053f0d92c62455…
2023-05-13 08:27 UTC2023-05N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05053a50430f4f…
2023-01-26 05:58 UTC2023-01N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-053bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-053a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020414-001PYRIDOSTIGMINE BROMIDE30MGTABLET / ORAL2003-02-05cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pyridostigmine BromidePYRIDOSTIGMINE BROMIDESurgeon General-Department of the Army (TSG-DA)0b296555-c32f-42db-b5f3-ea981a3dd2f82025-12-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 020414
application number: NDA020414
ndc (product): 72458-128

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 3 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
72458-128Pyridostigmine BromidePyridostigmine BromideSurgeon General-Department of the Army (TSG-DA)NDACurrent
72458-128Pyridostigmine BromidePyridostigmine BromideSurgeon General-Department of the Army (TSG-DA)NDACurrent
72458-128Pyridostigmine BromidePyridostigmine BromideSurgeon General-Department of the Army (TSG-DA)NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83588SUPPL 2025-09-30
83574SUPPL 2025-09-29
79838SUPPL 2024-10-08
79837SUPPL 2024-10-08
45784SUPPL2016-11-02
45783SUPPL2016-11-02
45782SUPPL2016-11-02
41353ORIG2003-04-25
34638ORIG2003-02-05
24948ORIG2003-02-05